Zoe M. Weinstein, MD

Assistant Professor, Medicine

Zoe Weinstein
617.414.7399
801 Massachusetts Ave Crosstown Center

Biography

Zoe M. Weinstein MD,MS, is a general internist and a graduate of the Boston University Addiction Medicine Fellowship. Her research interests include the health of urban underserved patients, especially in the areas of addiction and HIV. Her current clinical work and research are focused on long-term Office-Based Opioid Treatment (OBOT) with buprenorphine, the integration of addiction treatment with primary care and inpatient medical care. She is currently the director of Boston Medical Center’s Addiction Consult Service.

Education

  • University of California San Francisco, MD
  • Columbia University, BA

Publications

  • Published on 7/1/2018

    Weinstein ZM, Wakeman SE, Nolan S. Inpatient Addiction Consult Service: Expertise for Hospitalized Patients with Complex Addiction Problems. Med Clin North Am. 2018 Jul; 102(4):587-601. PMID: 29933817.

    Read at: PubMed
  • Published on 6/19/2018

    Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend. 2018 08 01; 189:166-171. PMID: 29958128.

    Read at: PubMed
  • Published on 12/1/2017

    Mehta AB, Weinstein Z, Walkey AJ. The Untold Toll of the Opioid Crisis on Intensive Care Units in the United States. Ann Am Thorac Soc. 2017 Dec; 14(12):1763-1765. PMID: 29192818.

    Read at: PubMed
  • Published on 9/9/2017

    Schiff DM, Drainoni ML, Weinstein ZM, Chan L, Bair-Merritt M, Rosenbloom D. A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences. J Subst Abuse Treat. 2017 Nov; 82:41-47. PMID: 29021114.

    Read at: PubMed
  • Published on 5/16/2017

    Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat. 2017 Aug; 79:12-19. PMID: 28673522.

    Read at: PubMed
  • Published on 5/11/2017

    Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, Walley AY. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017 Aug; 79:1-5. PMID: 28673521.

    Read at: PubMed
  • Published on 12/30/2016

    Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, Drainoni ML, Bachman SS, Samet JH. Long-term retention in Office Based Opioid Treatment with buprenorphine. J Subst Abuse Treat. 2017 Mar; 74:65-70. PMID: 28132702.

    Read at: PubMed
  • Published on 12/22/2016

    Schiff DM, Drainoni ML, Bair-Merritt M, Weinstein Z, Rosenbloom D. A Police-Led Addiction Treatment Referral Program in Massachusetts. N Engl J Med. 2016 12 22; 375(25):2502-2503. PMID: 28002701.

    Read at: PubMed
  • Published on 11/5/2016

    Weinstein ZM, Cheng DM, Quinn E, Hui D, Kim H, Gryczynski G, Samet JH. Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. Drug Alcohol Depend. 2017 Jan 01; 170:9-16. PMID: 27865152.

    Read at: PubMed
  • Published on 3/22/2016

    Thakarar K, Weinstein ZM, Walley AY. Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgrad Med J. 2016 Jun; 92(1088):356-63. PMID: 27004476.

    Read at: PubMed

View 1 more publications: View full profile at BUMC

View all profiles